Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
Rhea-AI Summary
Globus Medical (NYSE:GMED) will announce fourth-quarter and full-year 2025 financial results after market close on February 24, 2026. The company will host a teleconference and live webcast at 4:30 p.m. Eastern Time the same day.
Investors can access the live webcast and audio archive on the Globus Medical Investors page. Telephone participation requires advance registration to receive a dial-in number, unique passcode, and registrant ID.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
GMED’s modest -0.52% move occurred as several device peers were also lower: MASI -1.54%, BIO -0.38%, BRKR -4.21%, GKOS -1.96%, IRTC -3.32%. Scanner data flagged BIO with a sharper -13.82% move.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 16 | Q3 earnings scheduling | Neutral | +1.7% | Announced Q3 2025 earnings release date and post-close conference call. |
| Jul 17 | Q2 earnings scheduling | Neutral | -2.1% | Scheduled Q2 2025 results and 4:30 p.m. Eastern investor call. |
| Apr 17 | Q1 earnings scheduling | Neutral | -2.3% | Set Q1 2025 earnings date and standard webcast/telecom details. |
| Jan 30 | FY 2024 earnings scheduling | Neutral | -0.4% | Scheduled Q4 and full-year 2024 results and investor conference call. |
| Oct 15 | Q3 earnings scheduling | Neutral | +1.1% | Announced Q3 2024 release timing and access details for the call. |
Scheduling earnings releases and conference calls has typically led to modest, mixed single-day moves, with an average reaction of about -0.39% around similar announcements.
Over the past year, Globus Medical has repeatedly followed a consistent cadence of scheduling quarterly earnings releases and 4:30 p.m. Eastern conference calls, as seen on Oct 15, 2024, Jan 30, 2025, Apr 17, 2025, Jul 17, 2025, and Oct 16, 2025. These notices typically reference after‑market‑close releases and investor webcasts. Price reactions to these scheduling headlines have been small, both positive and negative, framing today’s Q4 and full‑year 2025 scheduling as part of an established communications pattern.
Historical Comparison
In the past five scheduling notices tagged “conferences,earnings,” GMED’s average one-day move was -0.39%, indicating typically small reactions around these routine communications.
Globus Medical has maintained a regular pattern of quarterly earnings scheduling releases from late 2024 through 2025, consistently pairing after-close results with 4:30 p.m. Eastern investor calls and archived webcasts.
Market Pulse Summary
This announcement sets the timing for Globus Medical’s Q4 and full-year 2025 results and the accompanying investor call on February 24, 2026. Historically, similar “conferences,earnings” scheduling releases produced small average moves of about -0.39%, suggesting they function mainly as routine communication. In context of prior preliminary 2025 sales and guidance updates, the upcoming call’s audited figures and commentary on business trends will be key items to monitor.
AI-generated analysis. Not financial advice.
AUDUBON, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December 31, 2025 after the market close on Tuesday, February 24, 2026. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call live via webcast on the Investors page of Globus Medical’s website at https://www.investors.globusmedical.com/news-events/events-webcasts.
To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
The audio archive will be available after the call on the Investors page of the Globus Medical website.
About Globus Medical, Inc.
Globus Medical, Inc. is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with health epidemics, pandemics and similar outbreaks, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, the successful integration of businesses that we have acquired or may acquire in the future, and other risks. For a discussion of these and other risks, uncertainties, and other factors that could affect our results, refer to the disclosures contained in our most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”), including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our subsequent filings with the SEC. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. Except as may be required by applicable law, we undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Contact:
Brian Kearns
Senior Vice President, Corporate Development and Investor Relations
Phone: (610) 930-1800
Email: investors@globusmedical.com
www.globusmedical.com
FAQ
When will Globus Medical (GMED) release Q4 and full-year 2025 results?
What time is the Globus Medical (GMED) earnings conference call on February 24, 2026?
How can investors access the Globus Medical (GMED) webcast and audio archive?
Do I need to register to join the Globus Medical (GMED) conference call by phone?
Will Globus Medical (GMED) provide a press release and where will it be posted?
Can analysts and investors ask questions during the Globus Medical (GMED) February 24, 2026 call?
